Driving alignment across our global Research & Development

16 July 2025

Dechra is reinforcing its commitment to the sustainable improvement of animal health and welfare globally with the permanent appointment of Dr. Cathy Knupp as Chief Scientific Officer (CSO).

With deep expertise gained from a distinguished career in animal health and pharmaceutical research, Cathy has already played a pivotal role in shaping Dechra’s global research and development (R&D) strategy since initially taking the role on an interim basis in October 2024. 

Jesper Nordengaard, Dechra CEO, said: “Cathy’s leadership has been instrumental in helping us drive innovation, enhance collaboration, and position our pipeline to fuel future growth.” 

“I am delighted we are able to benefit from her passion for science, deep industry knowledge, and ability to connect teams globally on a permanent basis.” 

Cathy’s permanent appointment marks a key milestone in strengthening Dechra’s capabilities and advancing a robust pipeline of innovative new products.